Schedule of Earnings Per Share, Basic and Diluted |
The following table presents the computation of basic and diluted net loss per share of common stock (in millions, except per share data): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | | 2022 | | 2021 | | 2022 | | 2021 | | | Class A | | Class A | | Class B | | Class A | | Class A | | Class B | | | (in thousands, except per share amounts) | Net loss attributable to common stockholders | | $ | (63,420) | | | $ | (55,109) | | | $ | (1,089) | | | $ | (144,121) | | | $ | (154,623) | | | $ | (10,553) | | Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted | | 122,339 | | | 114,218 | | | 2,257 | | | 121,094 | | | 107,952 | | | 7,368 | | Net loss per share attributable to common stockholders, basic and diluted | | $ | (0.52) | | | $ | (0.48) | | | $ | (0.48) | | | $ | (1.19) | | | $ | (1.43) | | | $ | (1.43) | |
|
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following securities were excluded from the computation of diluted net loss per share of common stock for the periods presented as their effect would have been antidilutive (in millions): | | | | | | | | | | | | | | | | | Number of Shares | | | As of September 30, | | | 2022 | | 2021 | | | (in thousands) | Stock options | | 2,514 | | | 5,175 | | RSUs | | 12,981 | | | 4,458 | | PSUs | | 267 | | | 109 | | MPSUs | | 2,174 | | | — | | Revest shares | | — | | | 448 | | Early exercised stock options | | — | | | 48 | | Shares issuable pursuant to the ESPP | | 194 | | | 83 | | Convertible senior notes (if-converted) | | 7,338 | | | 9,229 | | Total | | 25,468 | | | 19,550 | |
|
Schedule of Accumulated Other Comprehensive Income (Loss) |
For the three and nine months ended September 30, 2022 and 2021, components of accumulated other comprehensive (loss) income, net of taxes, were as follows (in thousands):
| | | | | | | | | | | | | | | | | | | Unrealized Loss on Available-for-Sale Securities | | Foreign Currency Translation Adjustment | | Total | Balance, June 30, 2022 | (11,987) | | | (555) | | | (12,542) | | Foreign currency translation adjustment | — | | | (22) | | | (22) | | Unrealized loss on available-for-sale securities | (114) | | | — | | | (114) | | Balance, September 30, 2022 | (12,101) | | | (577) | | | (12,678) | |
| | | | | | | | | | | | | | | | | | | Unrealized Gain on Available-for-Sale Securities | | Foreign Currency Translation Adjustment | | Total | Balance, June 30, 2021 | (120) | | | (141) | | | (261) | | Foreign currency translation adjustment | — | | | (186) | | | (186) | | Unrealized loss on available-for-sale securities | 27 | | | — | | | 27 | | Balance, September 30, 2021 | (93) | | | (327) | | | (420) | |
| | | | | | | | | | | | | | | | | | | Unrealized Loss on Available-for-Sale Securities | | Foreign Currency Translation Adjustment | | Total | Balance, December 31, 2021 | (2,242) | | | (385) | | | (2,627) | | Foreign currency translation adjustment | — | | | (192) | | | (192) | | Unrealized loss on available-for-sale securities | (9,859) | | | — | | | (9,859) | | Balance, September 30, 2022 | (12,101) | | | (577) | | | (12,678) | |
| | | | | | | | | | | | | | | | | | | Unrealized Gain on Available-for-Sale Securities | | Foreign Currency Translation Adjustment | | Total | Balance, December 31, 2020 | 105 | | | (99) | | | 6 | | Foreign currency translation adjustment | — | | | (228) | | | (228) | | Unrealized loss on available-for-sale securities | (198) | | | — | | | (198) | | Balance, September 30, 2021 | (93) | | | (327) | | | (420) | |
|